3-(2,2,2-trimethylhydrazine)propionate has been researched along with lactic acid in 5 studies
| Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (lactic acid) | Trials (lactic acid) | Recent Studies (post-2010) (lactic acid) |
|---|---|---|---|---|---|
| 251 | 35 | 105 | 46,263 | 3,349 | 19,053 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaka, N; Kirimoto, T; Miyake, H; Muranaka, Y | 1 |
| Asaka, N; Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Tajima, K | 1 |
| Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Tajima, K | 1 |
| Cirule, H; Dambrova, M; Liepinsh, E; Makrecka, M; Skapare, E; Svalbe, B | 1 |
| Berzina-Cimdina, L; Loca, D; Makrecka, M; Sevostjanovs, E; Sokolova, M; Tupureina, V; Zharkova-Malkova, O | 1 |
5 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and lactic acid
| Article | Year |
|---|---|
Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts.
Topics: Administration, Oral; Animals; Cardiovascular Agents; Carnitine; Coronary Circulation; Glucose; Glycolysis; Heart; Hypoglycemic Agents; Hypoxia; In Vitro Techniques; Insulin; Lactic Acid; Male; Methylhydrazines; Myocardial Contraction; Oxidation-Reduction; Palmitates; Phosphates; Rats; Rats, Sprague-Dawley | 1998 |
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiovascular Agents; gamma-Butyrobetaine Dioxygenase; Heart Failure; Heart Ventricles; Hemodynamics; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Rate | 2000 |
Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts.
Topics: Animals; Carnitine; Enzyme Inhibitors; gamma-Butyrobetaine Dioxygenase; Heart Function Tests; Hemodynamics; In Vitro Techniques; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Nifedipine; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation | 2000 |
Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats.
Topics: Animals; Blood Glucose; Body Weight; Cell Nucleus; Drug Combinations; Eating; Gene Expression Regulation; Hypoglycemic Agents; Insulin; Lactic Acid; Lipid Metabolism; Male; Metformin; Methylhydrazines; Myocardium; Obesity; PPAR alpha; PPAR gamma; Rats; Rats, Zucker; RNA, Messenger | 2011 |
Microencapsulation of mildronate in biodegradable and non-biodegradable polymers.
Topics: Animals; Capsules; Cardiovascular Agents; Kinetics; Lactic Acid; Male; Methylhydrazines; Polyesters; Polymers; Polystyrenes; Rabbits | 2014 |